Providing fertility care to men seropositive for human immunodeficiency virus: reviewing 10 years of experience and 420 consecutive cycles of in vitro fertilization and intracytoplasmic sperm injection
Mark V Sauer, Jeff G Wang, Nataki C Douglas, Gary S Nakhuda, Pratibashri Vardhana, Vuk Jovanovic, Michael M Guarnaccia, Mark V Sauer, Jeff G Wang, Nataki C Douglas, Gary S Nakhuda, Pratibashri Vardhana, Vuk Jovanovic, Michael M Guarnaccia
Abstract
Objective: To review 10 years of experience providing fertility care to men seropositive for human immunodeficiency virus (HIV) using sperm washing and in vitro fertilization with intracytoplasmic sperm injection (IVF-ICSI).
Design: Retrospective study.
Setting: University-based practice.
Patient(s): HIV-seropositive men with HIV-seronegative partners.
Intervention(s): IVF-ICSI, HIV testing of females and infants.
Main outcome measure(s): IVF performance, pregnancy rates, obstetrical outcomes, infection rates.
Result(s): We initiated 420 cycles (355 fresh and 65 frozen cycles) in 181 couples. Due to poor ovarian response, 16% of stimulations were canceled. The number of oocytes collected per retrieval was 15.0 +/- 0.5, providing 12.1 +/- 0.5 mature oocytes suitable for ICSI, yielding 9.0 +/- 0.3 embryos per couple. The overall clinical pregnancy rate/embryo transfer was 45%; ongoing/delivered pregnancy rate/embryo transfer was 37%. The most frequent obstetric complication was multiple gestation (41%), with 5% experiencing high order multiple birth. An attendant high rate of preterm delivery was noted, as 43% of infants were born premature. No maternal or neonatal HIV infections or deaths occurred.
Conclusion(s): We have found IVF-ICSI to be an expeditious and safe means for HIV-serodiscordant couples to achieve pregnancy with minimal risk of viral infection. Risks and liabilities of IVF-ICSI relate to multiple gestations and will occur in a significant number of participants.
Source: PubMed